These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17463193)

  • 1. Aggressive behavior and neuroleptic medication are associated with increased number of alpha1-adrenoceptors in patients with Alzheimer disease.
    Sharp SI; Ballard CG; Chen CP; Francis PT
    Am J Geriatr Psychiatry; 2007 May; 15(5):435-7. PubMed ID: 17463193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotic symptoms, aggression and restlessness in dementia.
    Ballard C; Gray A; Ayre G
    Rev Neurol (Paris); 1999; 155 Suppl 4():S44-52. PubMed ID: 10637938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anticonvulsants in agitation and behavior disorders in demented subjects. Report of 8 cases].
    Fahs H; Potiron G; Senon JL; Perivier E
    Encephale; 1999; 25(2):169-74. PubMed ID: 10370890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating the agitated Alzheimer patient.
    Zayas EM; Grossberg GT
    J Clin Psychiatry; 1996; 57 Suppl 7():46-51; discussion 52-4. PubMed ID: 8690697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia.
    Engelborghs S; Vloeberghs E; Le Bastard N; Van Buggenhout M; Mariën P; Somers N; Nagels G; Pickut BA; De Deyn PP
    Neurochem Int; 2008 May; 52(6):1052-60. PubMed ID: 18093695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression.
    Wang LY; Shofer JB; Rohde K; Hart KL; Hoff DJ; McFall YH; Raskind MA; Peskind ER
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):744-51. PubMed ID: 19700947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporary increases in problem behavior and sleep disruption following decreases in medication: a descriptive analysis of conditional rates.
    Rapp JT; Swanson G; Dornbusch K
    Behav Modif; 2007 Nov; 31(6):825-46. PubMed ID: 17932238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Before push comes to shove. Managing resident aggression requires a proactive approach.
    Olson JK
    Contemp Longterm Care; 2002 Jul; 25(7):32-3. PubMed ID: 12154621
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation and management of aggressive behavior in the elderly demented patient.
    Raskind MA
    J Clin Psychiatry; 1999; 60 Suppl 15():45-9. PubMed ID: 10418815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agitation and psychosis in dementia.
    Ballard C
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):913-7. PubMed ID: 17974863
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychosis-related disturbances. Psychosis, agitation, and disinhibition in Alzheimer's disease: definitions and treatment options.
    Lesser JM; Hughes S
    Geriatrics; 2006 Dec; 61(12):14-20. PubMed ID: 17184138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antipsychotics in geriatric institutions].
    Szulik J
    Vertex; 2007; 18(76):454-60. PubMed ID: 18273435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agitation and aggressiveness among the elderly population living in nursing or retirement homes in France.
    Léger JM; Moulias R; Robert P; Vellas B; Chapuy PH; Monfort JC; Khoshnood B; Bouee S; Rebah N; Gerard D
    Int Psychogeriatr; 2002 Dec; 14(4):405-16. PubMed ID: 12670061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction: the clinical impact of agitation in various psychiatric disorders: management consensus and controversies.
    Mintzer JE
    J Clin Psychiatry; 2006; 67 Suppl 10():3-5. PubMed ID: 16965189
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the use of the positive and negative syndrome scale-excited component as a criterion for administration of p.r.n. medication.
    Chaichan W
    J Psychiatr Pract; 2008 Mar; 14(2):105-13. PubMed ID: 18360196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic treatment of agitation and psychosis in dementia.
    Devanand DP; Levy SR
    J Geriatr Psychiatry Neurol; 1995 Oct; 8 Suppl 1():S18-27. PubMed ID: 8561840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To prescribe or not to prescribe? Atypical antipsychotic drugs in patients with dementia.
    Jeste DV; Meeks T
    South Med J; 2007 Oct; 100(10):961-3. PubMed ID: 17943030
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological treatment of Alzheimer's dementia: state of the art and current dilemmas.
    Omerovic M; Hampel H; Teipel SJ; Buerger K
    World J Biol Psychiatry; 2008; 9(1):69-75. PubMed ID: 17886162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The treatment of disturbed behavior in patients with dementia].
    van de Boogerd ME; Pisters-van Roy AA; Wiertz YD
    Ned Tijdschr Geneeskd; 1992 Jul; 136(29):1419-20. PubMed ID: 1353612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.